<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<tbody>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Inhibitors of CYP3A4</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact</content>:</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>The concomitant use of Fentanyl Citrate Injection and CYP3A4 inhibitors can increase the plasma concentration of fentanyl, resulting in increased or prolonged opioid effects, particularly when an inhibitor is added after a stable dose of Fentanyl Citrate Injection is achieved <content stylecode="italics">[see <linkhtml href="#LINK_64abdc73-c156-4ad9-a837-f92e78e1963d">Warnings and Precautions (5.3)</linkhtml>]</content>.</paragraph>After stopping a CYP3A4 inhibitor, as the effects of the inhibitor decline, the fentanyl plasma concentration will decrease <content stylecode="italics">[see <linkhtml href="#LINK_a0e3b629-b55b-404c-9c1a-02bf5af9d7ec">Clinical Pharmacology (12.3)</linkhtml>]</content>, resulting in decreased opioid efficacy or a withdrawal syndrome in patients who had developed physical dependence to fentanyl.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>If concomitant use is necessary, consider dosage reduction of Fentanyl Citrate Injection until stable drug effects are achieved <content stylecode="italics">[see <linkhtml href="#LINK_792e2be4-5d11-4119-8cf5-4f372890fb51">Dosage and Administration (2.1)</linkhtml>]</content>. Monitor patients for respiratory depression and sedation at frequent intervals.</paragraph>If a CYP3A4 inhibitor is discontinued, consider increasing the Fentanyl Citrate Injection dosage until stable drug effects are achieved.  Monitor for signs of opioid withdrawal<content stylecode="bold">.</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Examples:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g. ketoconazole), protease inhibitors (e.g., ritonavir), grapefruit juice.</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">CYP3A4 Inducers</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>The concomitant use of Fentanyl Citrate Injection and CYP3A4 inducers can decrease the plasma concentration of fentanyl <content stylecode="italics">[see <linkhtml href="#LINK_a0e3b629-b55b-404c-9c1a-02bf5af9d7ec">Clinical Pharmacology (12.3)</linkhtml>]</content>, resulting in decreased efficacy or onset of a withdrawal syndrome in patients who have developed physical dependence to fentanyl <content stylecode="italics">[see <linkhtml href="#LINK_64abdc73-c156-4ad9-a837-f92e78e1963d">Warnings and Precautions (5.3)</linkhtml>]</content>. </paragraph>After stopping a CYP3A4 inducer, as the effects of the inducer decline, the fentanyl plasma concentration will increase <content stylecode="italics">[see <linkhtml href="#LINK_a0e3b629-b55b-404c-9c1a-02bf5af9d7ec">Clinical Pharmacology (12.3)</linkhtml>]</content>, which could increase or prolong both the therapeutic effects and adverse reactions, and may cause serious respiratory depression.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">If concomitant use is necessary, consider increasing the Fentanyl Citrate Injection dosage until stable drug effects are achieved. Monitor for signs of opioid withdrawal. If a CYP3A4 inducer is discontinued, consider Fentanyl Citrate Injection dosage reduction and monitor for signs of respiratory depression.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Examples:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Rifampin, carbamazepine, phenytoin</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Benzodiazepines and Other Central Nervous System (CNS) Depressants</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">The concomitant use of Fentanyl Citrate Injection with CNS depressants my result in decreased pulmonary artery pressure and may cause hypotension.  Even small dosages of diazepam may cause cardiovascular depression when added to high dose or anesthetic dosages of Fentanyl Citrate Injection.  As postoperative analgesia, concomitant use of Fentanyl Citrate Injection can increase the risk of hypotension, respiratory depression, profound sedation, coma, and death<content stylecode="bold">.</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<paragraph>As postoperative analgesia, start with a lower dose of Fentanyl Citrate Injection and monitor patients for signs of respiratory depression, sedation, and hypotension. Fluids or other measures to counter hypotension should be available <content stylecode="italics">[see <linkhtml href="#LINK_525b43a6-2595-4273-8579-007bdbfcfc81">Warnings and Precautions (5.4)</linkhtml>]</content>.</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Examples:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Benzodiazepines and other sedatives/hypnotics, anxiolytics, barbiturates, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol.</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Serotonergic Drugs</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system has resulted in serotonin syndrome <content stylecode="italics">[see <linkhtml href="#LINK_458a2f79-048f-4ef6-a4ea-4576cc1d8444">Warnings and Precautions (5.7)</linkhtml>]</content>. </td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Discontinue Fentanyl Citrate Injection if serotonin syndrome is suspected. </td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Examples:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)..</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Monoamine Oxidase Inhibitors</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">MAOI interactions with opioids may manifest as serotonin syndrome <content stylecode="italics">[see <linkhtml href="#LINK_458a2f79-048f-4ef6-a4ea-4576cc1d8444">Warnings and Precautions (5.7)</linkhtml>]</content> or opioid toxicity (e.g., respiratory depression, coma) <content stylecode="italics">[see <linkhtml href="#LINK_cdf51fe0-7cdb-4c1b-90e3-b2ead73bf4ce">Warnings and Precautions (5.2)</linkhtml>]</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">The use of Fentanyl Citrate Injection is not recommended for patients taking MAOIs or within 14 days of stopping such treatment. </td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Examples:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Phenelzine, tranylcypromine, linezolid</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Mixed Agonist/Antagonist and Partial Agonist Opioid Analgesics</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">May reduce the analgesic effect of Fentanyl Citrate Injection and/or precipitate withdrawal symptoms.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention</content>:</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Avoid concomitant use.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Examples:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Butorphanol, nalbuphine, pentazocine, buprenorphine.</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Muscle Relaxants</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Fentanyl may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Monitor patients for signs of diminished diuresis and/or effects on blood pressure and increase the dosage of the diuretic as needed.</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Diuretics</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     "> Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Monitor patients for signs of diminished diuresis and/or effects on blood pressure and increase the dosage of the diuretic as needed.</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Anticholinergic Drugs</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">The concomitant use of anticholinergic drugs may increase risk of urinary retention and/or severe constipation, which may lead to paralytic ileus<content stylecode="bold">.</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention</content>:</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Monitor patients for signs of urinary retention or reduced gastric motility when Fentanyl Citrate Injection is used concomitantly with anticholinergic drugs<content stylecode="bold">.</content>
</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Neuroleptics</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Elevated blood pressure, with and without pre-existing hypertension, has been reported following administration of Fentanyl Citrate Injection combined with a neuroleptic <content stylecode="italics">see <linkhtml href="#LINK_49136ccb-85f8-4a73-a6b4-82ecedffd552">Warnings and Precautions (5.13)</linkhtml>]</content>.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">ECG monitoring is indicated when a neuroleptic agent is used in conjunction with Fentanyl Citrate Injection as an anesthetic premedication, for the induction of anesthesia, or as an adjunct in the maintenance of general or regional anesthesia.</td>
</tr>
<tr>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="bold">Nitrous oxide</content>
</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Nitrous oxide has been reported to produce cardiovascular depression when given with higher doses of Fentanyl Citrate Injection.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">
<content stylecode="italics">Intervention:</content>
</td>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     ">Monitor patients for signs of cardiovascular depression that may be greater than otherwise expected.</td>
</tr>
</tbody>
</table>